JMP Securities maintains $7 target on Esperion stock
JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...
JMP Securities maintains Exelixis stock with $41 target
JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.
Redwood Trust price target lowered to $8 from $9 at JMP Securities
JMP Securities analyst Steven DeLaney lowered the firm’s price target on Redwood Trust (RWT) to $8 from $9 and keeps an Outperform rating on ...
JMP Securities Remains a Hold on RLI (RLI)
JMP Securities analyst Matthew Carletti reiterated a Hold rating on RLI (RLI – Research Report) today. The company’s shares closed yesterday at ...
bovnews2h
Orchid Island Capital Inc (ORC) Stock: Unveiling Its Hidden Strengths
Orchid Island Capital Inc (ORC) stock saw a decline, ending the day at $7.94 which represents a decrease of $-0.08 or -1.00% from the prior close of $8.02. The stock opened at $8.01 and touched a low ...
bovnews5h
Alphabet Inc Class A (GOOGL) Stock: Greater Than Its Current Valuation?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 52.38% ...
Churchill Downs (NASDAQ:CHDN) Receives Market Outperform Rating from JMP Securities
JMP Securities restated their market outperform rating on shares of Churchill Downs (NASDAQ:CHDN – Free Report) in a report ...
Why ROKU Stock Is Rallying Today
Benchmark believes that Roku can benefit meaningfully from establishing partnerships with other platforms and further ...
JMP Securities Reaffirms “Market Outperform” Rating for BlackLine (NASDAQ:BL)
JMP Securities restated their market outperform rating on shares of BlackLine (NASDAQ:BL – Free Report) in a research report released on Wednesday morning,Benzinga reports. The firm currently has a ...
Nasdaq15d
Context Therapeutics initiated with an Outperform at JMP Securities
JMP Securities initiated coverage of Context Therapeutics (CNTX) with an Outperform rating and $4 price target Context is a $97.8M market cap clinical-stage biotechnology company focused on ...
Yahoo Finance21d
Alphabet stock hit with JMP downgrade on antitrust concerns
JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...
Nasdaq1mon
Solid Biosciences initiated with an Outperform at JMP Securities
JMP Securities analyst Silvan Tuerkcan initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $15 price target Solid is a clinical-stage biotechnology company focused on ...